Company intelligence / Profile preview

Freepoint Capital Group

Delaware, United Statesfreepointcg.com ↗

Ownership: Private
Development stage: Other

Overview

Freepoint Capital Group is an investment firm focused on healthcare innovation. It invests in and partners with enterprises and entrepreneurs to accelerate the development of healthcare products and services. The company primarily serves the healthcare industry—including technology, data science, life sciences, and care delivery sectors—and has made at least three investments to date. Its most recent known investment was in Orasis Pharmaceuticals' Series D round in October 2024.

Industry: Investors

Partnerships

Not specified; invests in various companies but no major pharma/biotech partnerships listed.

Beyond the preview

Go deeper on Freepoint Capital Group.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Freepoint Capital Group.

Explore the full profile